These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 32727790

  • 1. Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion.
    Nishi K, Ishikura S, Umebayashi M, Morisaki T, Inozume T, Kinugasa T, Aoki M, Nimura S, Swain A, Yoshida Y, Hasegawa S, Nabeshima K, Sakata T, Shirasawa S, Tsunoda T.
    Anticancer Res; 2020 Aug; 40(8):4663-4674. PubMed ID: 32727790
    [Abstract] [Full Text] [Related]

  • 2. Growth Suppression of Human Colorectal Cancer Cells with Mutated KRAS by 3-Deaza-cytarabine in 3D Floating Culture.
    Luo H, Nishi K, Ishikura S, Swain A, Morishige N, Yazaki R, Ohshima T, Shirasawa S, Tsunoda T.
    Anticancer Res; 2018 Jul; 38(7):4247-4256. PubMed ID: 29970558
    [Abstract] [Full Text] [Related]

  • 3. Establishment of a Three-dimensional Floating Cell Culture System for Screening Drugs Targeting KRAS-mediated Signaling Molecules.
    Tsunoda T, Ishikura S, Doi K, Iwaihara Y, Hidesima H, Luo H, Hirose Y, Shirasawa S.
    Anticancer Res; 2015 Aug; 35(8):4453-9. PubMed ID: 26168486
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Apremilast Induces Apoptosis of Human Colorectal Cancer Cells with Mutant KRAS.
    Nishi K, Luo H, Ishikura S, Doi K, Iwaihara Y, Wills L, Baillie GS, Sakata T, Shirasawa S, Tsunoda T.
    Anticancer Res; 2017 Jul; 37(7):3833-3839. PubMed ID: 28668883
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
    Courau T, Bonnereau J, Chicoteau J, Bottois H, Remark R, Assante Miranda L, Toubert A, Blery M, Aparicio T, Allez M, Le Bourhis L.
    J Immunother Cancer; 2019 Mar 14; 7(1):74. PubMed ID: 30871626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer.
    He W, Zhang H, Han F, Chen X, Lin R, Wang W, Qiu H, Zhuang Z, Liao Q, Zhang W, Cai Q, Cui Y, Jiang W, Wang H, Ke Z.
    Cancer Res; 2017 Nov 15; 77(22):6375-6388. PubMed ID: 28883004
    [Abstract] [Full Text] [Related]

  • 12. CD155/TIGIT signaling regulates the effector function of tumor-infiltrating CD8+ T cell by NF-κB pathway in colorectal cancer.
    Li S, Ding J, Wang Y, Wang X, Lv L.
    J Gastroenterol Hepatol; 2022 Jan 15; 37(1):154-163. PubMed ID: 34734434
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation.
    Charitou T, Srihari S, Lynn MA, Jarboui MA, Fasterius E, Moldovan M, Shirasawa S, Tsunoda T, Ueffing M, Xie J, Xin J, Wang X, Proud CG, Boldt K, Al-Khalili Szigyarto C, Kolch W, Lynn DJ.
    Br J Cancer; 2019 Jul 15; 121(1):37-50. PubMed ID: 31133691
    [Abstract] [Full Text] [Related]

  • 14. Ras activation induces expression of Raet1 family NK receptor ligands.
    Liu XV, Ho SS, Tan JJ, Kamran N, Gasser S.
    J Immunol; 2012 Aug 15; 189(4):1826-34. PubMed ID: 22798674
    [Abstract] [Full Text] [Related]

  • 15. Cancer Spheroid Proliferation Is Suppressed by a Novel Low-toxicity Compound, Pyra-Metho-Carnil, in a Context-independent Manner.
    Yoshida K, Nishi K, Ishikura S, Nakabayashi K, Yazaki R, Ohshima T, Suenaga M, Shirasawa S, Tsunoda T.
    Anticancer Res; 2022 Aug 15; 42(8):3993-4001. PubMed ID: 35896235
    [Abstract] [Full Text] [Related]

  • 16. CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration.
    Triki H, Charfi S, Bouzidi L, Ben Kridis W, Daoud J, Chaabane K, Sellami-Boudawara T, Rebai A, Cherif B.
    Life Sci; 2019 Aug 15; 231():116543. PubMed ID: 31176775
    [Abstract] [Full Text] [Related]

  • 17. Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.
    Costa D, Venè R, Benelli R, Romairone E, Scabini S, Catellani S, Rebesco B, Mastracci L, Grillo F, Minghelli S, Loiacono F, Zocchi MR, Poggi A.
    Front Immunol; 2018 Aug 15; 9():1150. PubMed ID: 29910806
    [Abstract] [Full Text] [Related]

  • 18. The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer.
    Gharagozloo M, Kalantari H, Rezaei A, Maracy MR, Salehi M, Bahador A, Hassannejad N, Narimani M, Sanei MH, Bayat B, Ghazanfari H.
    Bratisl Lek Listy; 2015 Aug 15; 116(5):296-301. PubMed ID: 25924638
    [Abstract] [Full Text] [Related]

  • 19. Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer.
    Shen Y, Wang Q, Qi Y, Cui B, Zhang Z, Su J, Liu X, Lu C, Ye H, Ju Y, Lu Z.
    Mol Med Rep; 2014 Aug 15; 10(2):977-82. PubMed ID: 24819058
    [Abstract] [Full Text] [Related]

  • 20. Myeloid-derived suppressor cells inhibit natural killer cells in myelodysplastic syndromes through the TIGIT/CD155 pathway.
    Yue J, Li J, Ma J, Zhai Y, Shen L, Zhang W, Li L, Fu R.
    Hematology; 2023 Dec 15; 28(1):2166333. PubMed ID: 36651499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.